FDA

The public’s faith in the safety and efficacy of prescription drugs and vaccines has been shaken as never before. There’s skepticism about the role the big pharma plays in rolling out new medications, yet there are amazing breakthroughs in treating once fatal diseases. And then there’s the price for critical treatments that can be beyond the reach for many. How did we get here and how can we fix it? We are joined by Dr Jerry Avorn, professor of medicine at Harvard University Medical School and author of the new book, “Rethinking Medications: Truth, Power and the Drugs you Take.”

The fired staffers were tasked with making sure medications given to animals work well and are safe.

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts DEI initiatives.

The court said that the challengers, a group called the Alliance for Hippocratic Medicine, had no right to be in court at all since neither the organization nor its members could show they had suffered any concrete injury.

From convenience stores to online, the tablet 'will be an available option for millions of people in the United States,' the director of the FDA's Center for Drug Evaluation and Research says.

The drug, lecanemab, was proven to moderately slow the disease in early stages. It also comes with the potential for some serious side effects, such as brain bleeding and brain inflammation.

If the Food and Drug Administration authorizes use of the drug, called molnupiravir, it would be the first oral COVID-19 treatment that could be taken at home.

The Texas Poison Center has received 260 calls with ivermectin poisoning. Ivermectin is a livestock dewormer, and people are using it to prevent or treat a coronavirus infection.

A lawsuit Texas filed against the San Antonio Independent School District last week is on shaky ground now that the Food and Drug Administration has granted full approval to one of the coronavirus vaccines.

The FDA amended its emergency use authorizations for the Pfizer and Moderna vaccines to allow for an additional dose for some immunocompromised people.